BD1047二臭化水素酸塩
|
|
- CAS番号.
- 138356-21-5
- 化学名:
- BD1047二臭化水素酸塩
- 别名:
- BD1047二臭化水素酸塩;BD 1047ジヒドロブロミド
- 英語名:
- BD 1047 dihydrobromide
- 英語别名:
- 169592;BD1047.2HBr;BD 1047 HBr;BD-1047;BD 1047;BD1047.2HBr(1K/g);BD 1047 (hydrobromide);N1-(3,4-DICHLOROPHENETHYL)-N1,N2,N2-TRIMETHYLETHANE-1,2-DIAMINE 2HBR;N1-(3,4-dichlorophenethyl)-N1,N2,N2-trimethylethane-1,2-diamine dihydrobromide;N-[2-(3,4-Dichlorophenyl)ethyl]-N,N',N'-trimethyl-1,2-ethanediamine dihydrobromide;n-[2-(3,4-dichlorophenyl)ethyl]-n,n',n'-trimethylethane-1,2-diamine dihydrobromide
- CBNumber:
- CB32755978
- 化学式:
- C13H22Br2Cl2N2
- 分子量:
- 437.04118
- MOL File:
- 138356-21-5.mol
|
BD1047二臭化水素酸塩 物理性質
- 貯蔵温度 :
- Inert atmosphere,2-8°C
- 溶解性:
- H2O: >5mg/mL
- 外見 :
- 粉
- 色:
- 白い
- 安定性::
- DMSOまたは蒸留水の溶液で-20°Cで最大3か月保存できます.
BD1047二臭化水素酸塩 価格
もっと(4)
メーカー |
製品番号 |
製品説明 |
CAS番号 |
包装 |
価格 |
更新時間 |
購入 |
富士フイルム和光純薬株式会社(wako)
|
W01TOC0956 |
BD1047二臭化水素酸塩
BD 1047 Dihydrobromide |
138356-21-5 |
10mg |
¥53000 |
2024-03-01 |
購入 |
富士フイルム和光純薬株式会社(wako)
|
W01TOC0956 |
BD1047二臭化水素酸塩
BD 1047 Dihydrobromide |
138356-21-5 |
50mg |
¥223000 |
2024-03-01 |
購入 |
Sigma-Aldrich Japan
|
B8562 |
BD 1047ジヒドロブロミド ≥95% (HPLC)
BD 1047 dihydrobromide ≥95% (HPLC) |
138356-21-5 |
5mg |
¥16000 |
2024-03-01 |
購入 |
Sigma-Aldrich Japan
|
B8562 |
BD 1047ジヒドロブロミド ≥95% (HPLC)
BD 1047 dihydrobromide ≥95% (HPLC) |
138356-21-5 |
25mg |
¥98800 |
2024-03-01 |
購入 |
BD1047二臭化水素酸塩 化学特性,用途語,生産方法
説明
BD 1047 is a selective antagonist of sigma-1 (σ
1) receptors (K
i = 0.9 nM in a radioligand binding assay). It is selective for σ
1 receptors with binding affinity values greater than 10,000 nM for human recombinant dopamine, opioid, PCP, and serotonin receptors
in vitro.
In vivo, pretreatment with BD 1047 protects against convulsions and lethality induced by cocaine (Item Nos.
16186 |
ISO60176) and reduces cocaine-induced locomotor activity. It reduces dystonias induced by the σ receptor agonists haloperidol and di-o-tolylguanidine (DTG) in rats in a dose-dependent manner.
In vivo administration of BD 1047 also attenuates mechanical allodynia and microglial activation in a rat model of bone cancer pain.
BD1047二臭化水素酸塩 上流と下流の製品情報
原材料
準備製品
BD1047二臭化水素酸塩 生産企業
Global( 73)Suppliers
BD1047二臭化水素酸塩 スペクトルデータ(1HNMR)
138356-21-5(BD1047二臭化水素酸塩)キーワード:
レスベラトロール
リモナバン
1-ベンジル-4-フェニル-1,4-ジヒドロピリジン-3,5-ニカルボン酸ジエチル
4α,9-エポキシセバン-3β,4,12,14,16β,17,20-ヘプタオール3-(3,4-ジメトキシベンゾアート)
2-(3,4-ジクロロフェニル)-N-(2-ジメチルアミノエチル)-N-メチルエタンアミン
- 138356-21-5
- n-[2-(3,4-dichlorophenyl)ethyl]-n,n',n'-trimethylethane-1,2-diamine dihydrobromide
- BD1047.2HBr
- N-[2-(3,4-Dichlorophenyl)ethyl]-N,N',N'-trimethyl-1,2-ethanediamine dihydrobromide
- BD 1047 HBr
- BD-1047;BD 1047
- 169592
- BD1047.2HBr(1K/g)
- BD 1047 (hydrobromide)
- 1,2-ethanediamine, N-[2-(3,4-dichlorophenyl)ethyl]-N,N',N'-trimethyl-, dihydrobromide
- N1-(3,4-dichlorophenethyl)-N1,N2,N2-trimethylethane-1,2-diamine dihydrobromide
- N1-(3,4-DICHLOROPHENETHYL)-N1,N2,N2-TRIMETHYLETHANE-1,2-DIAMINE 2HBR
- inhibit,Inhibitor,BD 1047 dihydrobromide,BD-1047 dihydrobromide,Sigma Receptor,BD1047 dihydrobromide
- BD1047二臭化水素酸塩
- BD 1047ジヒドロブロミド